Key Commercial Highlights • Fanapt net product sales rose 26% to $29.6 million; total prescriptions increased 32% and new-to-brand prescriptions surged 76% ® • NEREUS (tradipitant) launched via nereus.us, an innovative direct-to-consumer platform – the first new prescription medicine in more than 40 years for the prevention of vomiting induced by motion, with convenient online ordering and rapid direct home delivery TM • Full-year 2026 revenue guidance raised to $240-$290 million, including $10-30 million f ...